Cure51

Paris, France

Cure51 mission is to create a database of cancer survivors to leverage their exceptional biological features.

$16.3M raised

Mar 2024

Seed

Top Investors

Hitachi VenturesSofinnova PartnersLife Extension VenturesOlivier PomelXavier Niel

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Cure51 raised?

Cure51 has raised $16.3M in total funding. The most recent round was Seed. The last funding was announced in March 2024.

Who are Cure51's investors?

Cure51's investors include Hitachi Ventures, Sofinnova Partners, Life Extension Ventures, Olivier Pomel, Xavier Niel.

Where is Cure51 headquartered?

Cure51 is headquartered in Paris, France.

What does Cure51 do?

Cure51 mission is to create a database of cancer survivors to leverage their exceptional biological features.

What stage is Cure51 at?

Cure51 is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 19, 2024.

MLA

"Cure51 — Funding & Investors." VCBacked, March 19, 2024, https://www.vcbacked.co/company/cure51. Accessed June 4, 2026.

APA

VCBacked. (2024). Cure51 — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/cure51

Wikipedia (cite web)

{{cite web |title=Cure51 — Funding & Investors |url=https://www.vcbacked.co/company/cure51 |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 19, 2024.